By Sabela Ojea
22nd Century Group is selling its GVB Biopharma hemp/cannabis operations to Specialty Acquisition Corporation.
The biotechnology company on Monday said it signed an agreement with the Nevada-based blank-check company, an entity affiliated with GVB employees, for the sale of the franchise.
Under…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Subscribe Now
Already a subscriber?
Log In
Read the full article here
